Topics include, but are not limited to: adverse effects of exposure to drugs, pharmaceuticals, chemicals, and toxins, development and implementation of new approach methodologies (NAMs), development and implementation of regulatory guidelines and policies, exposure assessment and interventions to promote safer working environments, human health and environmental concerns associated with nanomaterials, impact of pollutants, contaminants, and chemicals on ecosystems and wildlife, risk assessment of chemicals, drugs, and other substances, use of computer models and in silico approaches to pred
